Song Hong
SENIOR MEMBER
- Joined
- Jan 4, 2020
- Messages
- 5,058
- Reaction score
- -25
- Country
- Location
GoS rather Singapore not use China vaccine and fall sick. Using evaluation as a pretext, GoS keep saying lack of data about China vaccine. Meanwhile neighbours of Singapore and many others are already deploying Sinovac/Sinopharm large scale.
In fact, China vaccine is the most widely deployed in the world due to Chinese superior manufacturing capabilities. By now China vaccine would have more data points than Pfizer or Moderna.
***********
The Health Sciences Authority (HSA) is still evaluating the safety and efficacy of the Sinovac vaccine and waiting for data from the manufacturer, Associate Professor Kenneth Mak, director of medical services at the Ministry of Health, said yesterday.
Singapore received its first shipment of Sinovac's Covid-19 vaccine on Feb 23 as part of its advance purchase agreement with the manufacturer, but it has yet to approve the jab for use here.
Yesterday, Prof Mak said that while HSA waits for the outstanding information, it is continuing to do its due diligence and is tracking how the vaccine is used in other countries.
In fact, China vaccine is the most widely deployed in the world due to Chinese superior manufacturing capabilities. By now China vaccine would have more data points than Pfizer or Moderna.
***********
The Health Sciences Authority (HSA) is still evaluating the safety and efficacy of the Sinovac vaccine and waiting for data from the manufacturer, Associate Professor Kenneth Mak, director of medical services at the Ministry of Health, said yesterday.
Singapore received its first shipment of Sinovac's Covid-19 vaccine on Feb 23 as part of its advance purchase agreement with the manufacturer, but it has yet to approve the jab for use here.
Yesterday, Prof Mak said that while HSA waits for the outstanding information, it is continuing to do its due diligence and is tracking how the vaccine is used in other countries.
HSA still evaluating Sinovac shot, needs more data from manufacturer
The Health Sciences Authority (HSA) is still evaluating the safety and efficacy of the Sinovac vaccine and waiting for data from the manufacturer, Associate Professor Kenneth Mak, director of medical services at the Ministry of Health, said yesterday. Read more at straitstimes.com.
www.straitstimes.com
Last edited: